Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR1 |
Variant | P366L |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | FGFR1 P366L lies within the extracellular domain of the Fgfr1 protein (UniProt.org). P366L has not been characterized and therefore its effect on Fgfr1 protein function is unknown (PubMed, Oct 2024). |
Associated Drug Resistance | |
Category Variants Paths |
FGFR1 mutant FGFR1 P366L |
Transcript | NM_023110.3 |
gDNA | chr8:g.38419720G>A |
cDNA | c.1097C>T |
Protein | p.P366L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_006716311 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716311.1 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013221.1 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_001174066.2 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716303.3 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716312.2 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013222 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_047421570.1 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_001174066 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716312.2 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_023110 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013226.2 | chr8:g.38419552G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_023105.3 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_011544448 | chr8:g.38419552G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716310.3 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_001174063.2 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_001174066.1 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716311.1 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_011544448.1 | chr8:g.38419552G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013226.1 | chr8:g.38419552G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013222.2 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716310.4 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_001174063 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_023105.2 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_023105 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_023110.3 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013221 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_001174063.1 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716303 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716304.1 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013221.2 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716312 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_017013226 | chr8:g.38419552G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716303.4 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716304.2 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_011544448.2 | chr8:g.38419552G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716304 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
XM_006716310 | chr8:g.38418294G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
NM_023110.2 | chr8:g.38419720G>A | c.1097C>T | p.P366L | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|